Treatment response and associated factors of hemoporfin-mediated photodynamic therapy for port-wine stains: A systematic review and meta-analysis
Journal of the American Academy of Dermatology · 2026-10
DOI: 10.1016/j.jaad.2026.09.102 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of the American Academy of Dermatology, 2026-10. Verfasst von Jinxin Qi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Dermatology, Clinical Institute of Inflammation and…. Die Arbeit nennt 4 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Ne…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Qi, J., Wang, Y., Guo, L., Li, Y., Wang, Y., & Jiang, X. (2026). Treatment response and associated factors of hemoporfin-mediated photodynamic therapy for port-wine stains: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.09.102
Vancouver
Qi J, Wang Y, Guo L, Li Y, Wang Y, Jiang X. Treatment response and associated factors of hemoporfin-mediated photodynamic therapy for port-wine stains: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.09.102
BibTeX
@article{Qi2026,
author = {Qi, Jinxin and Wang, Yuanting and Guo, Linghong and Li, Yu and Wang, Yukun and Jiang, Xian},
title = {Treatment response and associated factors of hemoporfin-mediated photodynamic therapy for port-wine stains: A systematic review and meta-analysis},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2026.09.102}
}
EUVIMED